COVID-19

NACDS' new report highlights how integrating pharmacies and pharmacists into value-based programs and alternative payment models will help support the Biden administration’s refreshed vision for the Center for Medicare and Medicaid Innovation.

Moderna’s revised application, which was originally submitted in September, comes as the FDA is expected to authorize Pfizer-BioNTech’s booster shots for all adults as early as this week.